亮丙瑞林
亮丙瑞林结构式
|
常用名 | 亮丙瑞林 | 英文名 | Leuprolide TFA |
|---|---|---|---|---|
| CAS号 | 53714-56-0 | 分子量 | 1209.40 | |
| 密度 | 1.4±0.1 g/cm3 | 沸点 | N/A | |
| 分子式 | C59H84N16O12 | 熔点 | N/A | |
| MSDS | N/A | 闪点 | N/A | |
| 符号 |
GHS08 |
信号词 | Danger |
|
Estradiol, but not testosterone, heightens cortisol-mediated negative feedback on pulsatile ACTH secretion and ACTH approximate entropy in unstressed older men and women.
Am. J. Physiol. Regul. Integr. Comp. Physiol. 306(9) , R627-35, (2014) How sex steroids modulate glucocorticoid feedback on the hypothalamic-pituitary-corticotrope (HPC) unit is controversial in humans. We postulated that testosterone (T) in men and estradiol (E2) in women govern unstressed cortisol-mediated negative feedback on... |
|
|
Two different formulations with equivalent effect? Comparison of serum estradiol suppression with monthly goserelin and trimonthly leuprolide in breast cancer patients.
Med. Oncol. 30(1) , 354, (2013) Data comparing the efficacy of monthly and trimonthly formulations of LHRH agonists are lacking. The aim of this study was to compare the effects of monthly goserelin and trimonthly leuprolide on estradiol levels. A total of 79 early breast cancer patients re... |
|
|
Novasure as a mechanical endometrial preparation agent in large uteri.
JSLS 16(4) , 537-41, (2012) We evaluated Novasure ablation as a mechanical endometrial preparation agent before Roller Ball endometrial ablation in lieu of GnRH agonists in large uteri.A retrospective chart review of 20 consecutive patients undergoing Novasure ablation for mechanical en... |
|
|
Comprehensive management of diffuse leiomyomatosis in a patient with Alport syndrome.
P. R. Health Sci. J. 32(4) , 200-2, (2013) Alport syndrome with diffuse leiomyomatosis (ASDL) is a complex combination that doesn't have a specific course of treatment. In this case report, we present a 44-year-old woman with ASDL and detail her treatment. The patient presented at the emergency room (... |
|
|
A rare case of lymphangiomyomatosis treated with leuprolide acetate: five-years follow-up.
Eur. J. Gynaecol. Oncol. 34(3) , 278-9, (2013) Lymphangiomyomatosis (LAM) is a rare and systemic disease that is characterized by the abnormal proliferation of smooth muscle-like cells in the lungs and along the axial lymphatic system. The authors herein present a rare case of LAM that was treated with lo... |
|
|
[A posteriori biological demonstration of the concept of hormone-radiotherapy combination in cancer of the prostate].
Bull. Cancer 100(5) , 415-6, (2013)
|
|
|
Spontaneous reports of seizure in association with leuprolide (lupron depot), goserelin (zoladex implant), and naferelin (synarel nasal spray).
Obstet. Gynecol. 121(5) , 1107, (2013)
|
|
|
A role for androgen reduction treatment in Kennedy disease?
Muscle Nerve 47(6) , 789, (2013)
|
|
|
Leuprorelin: a leading role in advanced prostate cancer therapy.
Hosp. Med. 64(6) , 360-3, (2003) Leuprorelin is a luteinizing hormone-releasing hormone analogue, licensed in the UK for the treatment of advanced prostate cancer. This review highlights the efficacy and tolerance of this agent and the benefits provided for developing patient-centred therapy... |
|
|
Global update on defining and treating high-risk localized prostate cancer with leuprorelin: a Japanese perspective--the effect of primary androgen deprivation therapy on stage C prostate cancer.
BJU Int. 99 Suppl 1 , 10-2; discussion 17-8, (2007) Stage C prostate cancer, where the tumour has extended beyond the capsule of the prostate, is typically a high-risk disease. According to the National Cancer Institute Physician Data Query the treatments of choice for stage C disease comprise external beam ra... |